Skip to main content

in reply to π••π•šπ•’π•Ÿπ•–π•’ πŸ³οΈβ€βš§οΈπŸ¦‹

in reply to π••π•šπ•’π•Ÿπ•–π•’ πŸ³οΈβ€βš§οΈπŸ¦‹

But you can certainly patent new manufacturing processes, forms, and delivery of insulin as they are "novel." The effect of regulatory requirements written by lobbyists are one way of ensuring the markets are tightly controlled by IP investors
⇧